Anhydrotetracycline (hydrochloride)
(Synonyms: 盐酸脱水四环素) 目录号 : GC16227Regulator of TetR and revTetR transcriptional repressors
Cas No.:13803-65-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Anhydrotetracycline (hydrochloride) (ATC) is a powerful effector for the tetracycline repressor (TetR) and reverse tetracycline repressor (revTetR) systems [1].
Tetracycline repressor (TetR) is an effector-regulated DNA-binding protein that binds tightly to its palindromic tetO operator DNA in the absence of effector, thereby blocking the transcription of any downstream genes. Binding of tetracycline (TC) or anhydrote-tracycline (ATC) to TetR causes the repressor to dissociate from the DNA and gene transcription can occur. Contrary to TetR, reverse tetracycline repressor (revTetR) mutant binds tetO only in the presence of ATC [2][3].
Anhydrotetracycline (hydrochloride) is a powerful effector for TetR and revTetR systems. Anhydrotetracycline (ATC) bound TetR with a 500-fold higher affinity and represented the most efficient inducer [2]. ATC bound the Tet repressor 35-fold more potent than Tet [4]. However, ATC acted as a corepressor in revTetR variant. In β-galactosidase (β-gal) assays, TetR inhibitedβ-gal expression to nearly 1%, while ~100% expression was accomplished in the presence of 0.4 μM ATC. RevTetR produced almost 100%β-gal activity in the absence of ATC, while the presence of 0.4 μM ATC resulted in a 5-fold decrease ofβ-gal activity [2].
References:
[1].? Gossen M, Bujard H. Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells. Nucleic Acids Res. 1993 Sep 11;21(18):4411-2.
[2].? Kamionka A, Bogdanska-Urbaniak J, Scholz O, et al. Two mutations in the tetracycline repressor change the inducer anhydrotetracycline to a corepressor. Nucleic Acids Res. 2004 Feb 4;32(2):842-7.
[3].? Resch M, Striegl H, Henssler EM, et al. A protein functional leap: how a single mutation reverses the function of the transcription regulator TetR. Nucleic Acids Res. 2008 Aug;36(13):4390-401.
[4].? Degenkolb J, Takahashi M, Ellestad GA, et al. Structural requirements of tetracycline-Tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the Tet repressor. Antimicrob Agents Chemother. 1991 Aug;35(8):1591-5.
无水四环素(盐酸盐)(ATC) 是四环素阻遏物 (TetR) 和反向四环素阻遏物 (revTetR) 系统的强大效应物 [1]。
四环素阻遏物 (TetR) 是一种效应子调节的 DNA 结合蛋白,在没有效应子的情况下与其回文 tetO 操纵子 DNA 紧密结合,从而阻断任何下游基因的转录。四环素 (TC) 或无水四环素 (ATC) 与 TetR 的结合会导致阻遏物与 DNA 解离,从而发生基因转录。与 TetR 相反,反向四环素阻遏物 (revTetR) 突变体仅在存在 ATC 的情况下结合 tetO [2][3]。
Anhydrotetracycline(盐酸盐)是 TetR 和 revTetR 系统的强大效应物。无水四环素 (ATC) 以高 500 倍的亲和力结合 TetR,是最有效的诱导剂 [2]。 ATC 结合 Tet 阻遏物的效力是 Tet 的 35 倍 [4]。然而,ATC 在 revTetR 变体中充当辅阻遏物。在 β-半乳糖苷酶 (β-gal) 测定中,TetR 将 β-gal 表达抑制到近 1%,而在 0.4 μM ATC 存在的情况下实现了约 100% 的表达。在没有 ATC 的情况下,RevTetR 产生几乎 100% 的β-gal 活性,而存在 0.4 μM ATC 时,β-gal 活性降低了 5 倍 [2]。
Cas No. | 13803-65-1 | SDF | |
别名 | 盐酸脱水四环素 | ||
化学名 | (4S,4aS,12aS)-4-(dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide hydrochloride | ||
Canonical SMILES | CN([C@@H]1C(O)=C(C([C@@]2([C@@]1([H])CC3=C(C2=O)C(O)=C4C(O)=CC=CC4=C3C)O)=O)C(N)=O)C.Cl | ||
分子式 | C22H22N2O7 • HCl | 分子量 | 462.9 |
溶解度 | 20mg/ml in DMSO, 12mg/ml in DMF, 2mg/ml in Ethanol | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.1603 mL | 10.8015 mL | 21.6029 mL |
5 mM | 0.4321 mL | 2.1603 mL | 4.3206 mL |
10 mM | 0.216 mL | 1.0801 mL | 2.1603 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。